← Open Payments lookup

MICHELLE MAROSOK: Open Payments

NPI 1669166112 · LA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,663 in 45 payments from 15 companies in 2025. Trend: 2023 $1,551 · 2024 $3,331 · 2025 $1,663

Food & beverage: $1,281Long term medical supply or device loan: $382
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation7$454
Janssen Biotech, Inc.4$335
ABBVIE INC.8$239
AstraZeneca Pharmaceuticals LP5$110
Eisai Inc.4$94
Exelixis Inc.3$77
GENZYME CORPORATION2$73
PFIZER INC.3$70
Merck Sharp & Dohme LLC2$55
Bayer Healthcare Pharmaceuticals Inc.2$41

Products named: KISQALI, RYBREVANT, EPKINLY, Lenvima, IMBRUVICA, CABOMETYX, ELREXFIO, SCEMBLIX.

Industry payments across CA — which companies pay providers there.